dismiss

Save the Date - Our next Clean Sweep Live Auction will be on Tuesday, September 26th at 9:30AM EST

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment

 

MRI Homepage

Michigan appeals court case could test lay-ownership of MR facility laws Must imaging facilities be owned by doctors?

PET/MR scans can assess pediatric cancer survivor health Study targets chemotherapy after-effects in young patients

FDA approves sale of SyMRI IMAGE software for GE Healthcare MR scanners Reduces scan times

FDA panel: Add retention warning to gadolinium contrast agents MIDAC also votes to increase studies conducted by contrast manufacturers

Study finds MR can measure kidney scarring and predict future kidney function Could also test new anti-scarring treatments

Resilience Capital Partners acquires three medical device service and manufacturing companies Forms Innovatus Imaging Corporation

Children’s National Health System first U.S. pediatric institution to use MR-HIFU Requires no incision

Doctors to apply for CT and MR scan permission under Anthem Aimed at reducing hospital outpatient imaging services

Imaging technology scans reveal trend in kidney cancer rates may be at an end Used CT, MRI, PET and ultrasound scans

MR isn't helpful for evaluating children with sports-related concussion symptoms Findings provide 'important guidance'

Researchers continue to look
for brain-based biomarkers

New guidelines advise against the use of brain imaging to diagnose chronic pain

por Lauren Dubinsky , Senior Reporter
A task force of researchers from around the world released new guidelines that recommend against the use of brain imaging to diagnose chronic pain.

With current imaging technology it’s impossible to determine whether a patient is experiencing chronic pain, according to Dr. Karen Davis, pain researcher at the Krembil Research Institute in Toronto, who led the task force. She argued that only the patient can provide that information, since pain is subjective.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory DOTmed Certified



Data from the Institute of Medicine of The National Academies revealed that 100 million Americans suffer from chronic pain. That’s more than the combined incidence of diabetes, coronary heart disease, stroke and cancer.

“Currently, physicians use a variety of approaches to decide on chronic pain treatments that relate to many medical and practical issues,” Davis told HCB News. “The method that is used is effective for some patients but not for many others.”

Physicians take into consideration the severity of the pain, other factors that accompany the pain, such as inflammation, other medical conditions the patient may have that prevent them from using some classes of drugs, the side effects of treatment, and what would be tolerable for the patient.

Recent advancements in brain imaging have led to a greater understanding of acute and chronic pain. That prompted a search for brain-based biomarkers for pain in order to offer patients more personalized treatment options.

Brain imaging is also in high demand among the legal community for use as a “lie detector” for chronic pain. Davis refers to that practice as inappropriate and unethical because pain varies between individuals and even within an individual at different times.

The new guidelines, which are published in the journal Nature Review: Neurology, state that any brain-based biomarkers should only be used as an adjunct to subjective reports of pain even if testing is improved and valid protocols are developed.

Davis and her team are working toward finding biomarkers for chronic pain to help provide more personalized treatment. The task force hopes the guidelines will be used by health care systems, governments, and legal policy makers as a blueprint for moving forward with research.

“Through brain imaging, we may be able to find particular features of the brain in some patients that are present when a particular treatment is effective, and other features that are present when that treatment is not,” said Davis. “Then, we would be able to match the patient to treatment.”

Back to HCB News
  Pages: 1

MRI Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente a Sua Perceção da Marca
Leilões + Vendas Privadas
Comece
O mais melhor preço
Comprar Equipamento/Peças
Encontre
O preço o mais baixo
Notícia diária
Leia
A notícia a mais atrasada
Diretório
Browse tudo
DOTmed Usuários
Ética no DOTmed
Veja o nosso
Programa das éticas
O ouro parte o programa do vendedor
Receba PH
Pedidos
Programa do negociante do serviço do ouro
Receba RFP/PS
Pedidos
Fornecedores de Healthcare
Veja tudo
Ferramentas de HCP
Trabalhos/Treinamento
Achado/suficiência
Um trabalho
Parts Hunter +EasyPay
Comece as peças
Citações
Certificado recentemente
Vista recentemente
Usuários certificados
Recentemente Rated
Vista recentemente
Usuários certificados
Central Rental
Equipamento do aluguel
Para menos
Vender Equipamentos/Peças
Comece
A maioria de dinheiro
Preste serviços de manutenção ao Forum dos técnicos
Ajuda do achado
E conselho
Simples RFP
Comece o equipamento
Citações
Mostra de comércio virtual
Serviço do achado
Para o equipamento
O acesso e o uso deste local são sujeitos aos termos e às condições do nosso OBSERVAÇÃO LEGAL & OBSERVAÇÃO DA PRIVACIDADE
Propriedade de e proprietário DOTmeda .com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
TODOS OS DIREITOS RESERVADOS